DC Vaccination for Postremission Therapy in AML

Update Il y a 4 ans
Reference: NCT01734304

Woman and Man

  • | Country :
  • Germany
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The aim of this study is to determine the feasibility and safety of an autologous DC immunotherapy in patients with AML of non-favorable risk profile.


Inclusion criteria

  • Acute Myeloid Leukemia

Links